The NRG Oncology Breast Cancer Committee’s purpose is to oversee the Breast Cancer Working Groups which aim to improve the lives of patients with breast cancers by designing and conducting practice-changing multi-institutional clinical trials and translational research. These include Local Regional, Rare, and Translational Working Groups and focus on developing and testing innovative advanced surgical, radiation oncology, and systemic (including chemotherapy and other targeted/biologic therapies) technologies for patients with breast malignancies. Additionally, this committee is committed to identifying and rectifying disparities in patient outcomes within this population.
The goals of this committee include goals and initiatives for the management of breast cancers, identify strategies to improve survival and maintain quality of life, developing and managing currently active and developing NRG clinical trials on the prevention, diagnosis, and treatment of breast cancers, and exploring potential translational research and biomarker development for incorporation into future clinical trials. This group meets at the NRG Semiannual Meetings and ad-hoc as necessary.